CONMED (CNMD) Earnings Date, Estimates & Call Transcripts → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free cnmd Stock Alerts $80.03 -0.11 (-0.14%) (As of 03/28/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateApr. 24EstimatedActual EPS (Jan. 31) $1.06 Missed By -$0.05 Consensus EPS (Jan. 31) $1.11 Get CONMED Earnings AlertsEnter your email address below to receive the latest news and earnings results for CNMD and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCNMD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CNMD Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Insiders ExposedThis consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. CONMED Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.89$0.89$0.89 Q2 20241$1.07$1.07$1.07 Q3 20241$1.10$1.10$1.10 Q4 20241$1.28$1.28$1.28 FY 20244$4.34$4.34$4.34 Q1 20251$1.26$1.26$1.26 Q2 20251$1.28$1.28$1.28 Q3 20251$1.46$1.46$1.46 CNMD Earnings Date and InformationCONMED last announced its quarterly earnings results on January 31st, 2024. The reported $1.06 earnings per share for the quarter, missing analysts' consensus estimates of $1.11 by $0.05. The business had revenue of $327.05 million for the quarter, compared to analyst estimates of $332.94 million. CONMED has generated $2.04 earnings per share over the last year ($2.04 diluted earnings per share) and currently has a price-to-earnings ratio of 39.2. Earnings for CONMED are expected to grow by 30.65% in the coming year, from $4.34 to $5.67 per share. CONMED has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 24th, 2024 based off prior year's report dates.Read More CONMED Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 4/24/2024Estimated)------- 1/31/2024Q4 2023$1.11$1.06($0.05)$1.07$332.94 million$327.05 million10/25/2023Q3 2023$0.83$0.90+$0.07$1.30$301.22 million$304.58 million 7/26/2023Q2 2023$0.79$0.83+$0.04$1.23$306.15 million$317.70 million 4/26/2023Q1 2023$0.60$0.66+$0.06$1.26$266.66 million$295.47 million 2/2/2023Q4 2022$0.93$0.42($0.51)($0.02)$302.48 million$250.87 million 10/26/2022Q3 2022$0.75$0.77+$0.02$0.06$282.23 million$275.09 million Get the Latest News and Ratings for CNMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter. 7/27/2022Q2 2022$0.76$0.76-$7.17$273.78 million$277.19 million5/4/2022Q1 2022$0.62$0.70+$0.08$0.93$235.55 million$242.33 million1/26/2022Q4 2021$1.05$1.07+$0.02$1.39$277.45 million$273.97 million10/27/2021Q3 2021$0.77$0.80+$0.03$1.13$255.22 million$248.83 million7/28/2021Q2 2021$0.62$0.71+$0.09$1.01$247.87 million$255.16 million4/28/2021Q1 2021$0.43$0.63+$0.20$0.95$217.44 million$232.68 million CONMED Earnings - Frequently Asked Questions When is CONMED's earnings date? CONMED has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 24th, 2024 based off last year's report dates. Learn more on CNMD's earnings history. Did CONMED beat their earnings estimates last quarter? In the previous quarter, CONMED (NYSE:CNMD) missed the analysts' consensus estimate of $1.11 by $0.05 with a reported earnings per share (EPS) of $1.06. Learn more on analysts' earnings estimate vs. CNMD's actual earnings. How much revenue does CONMED generate each year? CONMED (NYSE:CNMD) has a recorded annual revenue of $1.24 billion. How much profit does CONMED generate each year? CONMED (NYSE:CNMD) has a recorded net income of $64.46 million. CNMD has generated $2.04 earnings per share over the last four quarters. What is CONMED's price-to-earnings ratio? CONMED (NYSE:CNMD) has a trailing price-to-earnings ratio of 39.18 and a forward price-to-earnings ratio of 18.41. The price/earnings-to-growth ratio is 0.7. What is CONMED's EPS forecast for next year? CONMED's earnings are expected to grow from $4.34 per share to $5.67 per share in the next year, which is a 30.65% increase. More Earnings Resources from MarketBeat Related Companies: TransMedics Group Earnings Results LivaNova Earnings Results InMode Earnings Results Soleno Therapeutics Earnings Results Integer Earnings Results BioLife Solutions Earnings Results Masimo Earnings Results Rhythm Pharmaceuticals Earnings Results Ginkgo Bioworks Earnings Results PTC Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Lululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings callImpinj stock surges on strong earnings and guidanceAirbnb stock bulls just went all in before earnings This page (NYSE:CNMD) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research Advisory Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CONMED Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.